Arkolith/Insider Trading/WHWK/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed Apr 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$900K
Net Open-Market Flow
-$900K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2026Sell(S)64K$3.40$217K533K
Apr 7, 2026Sell(S)94K$3.43$323K597K
Apr 6, 2026Sell(S)102K$3.51$359K691K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001995275-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML